Oscar Health (OSCR) Expected to Announce Earnings on Tuesday

Oscar Health (NYSE:OSCR) is expected to announce its Q4 2025 results before the market opens on Tuesday, February 10th. Analysts expect Oscar Health to post earnings of ($0.84) per share and revenue of $3.1234 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 8:00 AM ET.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. The firm had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.22) earnings per share. On average, analysts expect Oscar Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Stock Performance

OSCR stock opened at $14.00 on Tuesday. The stock has a market capitalization of $3.71 billion, a PE ratio of -12.50 and a beta of 1.90. The stock’s 50 day simple moving average is $15.98 and its 200 day simple moving average is $16.81. Oscar Health has a 12-month low of $11.20 and a 12-month high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $13.00 to $25.00 in a report on Tuesday, November 25th. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. The Goldman Sachs Group assumed coverage on Oscar Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target for the company. Finally, Wells Fargo & Company cut their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. One investment analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Reduce” and a consensus price target of $17.00.

Insider Buying and Selling

In other news, insider Janet Liang sold 7,338 shares of Oscar Health stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the transaction, the insider owned 172,527 shares of the company’s stock, valued at $2,862,222.93. The trade was a 4.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mario Schlosser sold 23,038 shares of the business’s stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.65, for a total transaction of $406,620.70. Following the transaction, the insider owned 350,180 shares of the company’s stock, valued at approximately $6,180,677. This trade represents a 6.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 483,307 shares of company stock worth $7,635,300 in the last three months. 25.11% of the stock is owned by company insiders.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently made changes to their positions in the business. Quarry LP increased its stake in shares of Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares during the period. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio acquired a new stake in shares of Oscar Health during the 1st quarter worth approximately $30,000. Binnacle Investments Inc acquired a new position in shares of Oscar Health in the 2nd quarter valued at $75,000. Finally, National Bank of Canada FI acquired a new stake in Oscar Health during the third quarter valued at $81,000. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.